merestinib (Compound)

Compound:

merestinib (239c791a-e256-4b91-9670-d1bc930aa31b)

Synonyms:Merestinib, 1206799-15-6, LY2801653, LY-2801653, N-(3-fluoro-4-((1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5-yl)oxy)phenyl)-1-(4-fluorophenyl)-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxamide, Merestinib [USAN], N-[3-fluoro-4-[1-methyl-6-(1H-pyrazol-4-yl)indazol-5-yl]oxyphenyl]-1-(4-fluorophenyl)-6-methyl-2-oxopyridine-3-carboxamide, Merestinib (LY2801653), 5OGS5K699E, 3-Pyridinecarboxamide, N-(3-fluoro-4-((1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5-yl)oxy)phenyl)-1-(4-fluorophenyl)-1,2-dihydro-6-methyl-2-oxo-

Pubchem:PUBCHEM:44603533

Id:5a117168-82fa-557e-aa3a-270946a70d06

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View merestinib's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for merestinib.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with merestinib.

Results found

Linked to

	Label	Description
	BRD-K18961567-001-01-1 Substance (Entity type)	A Substance
	merestinib negatively regulates SNAP25 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	merestinib negatively regulates CHIC2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	merestinib bioactivity Tyrosine-protein kinase Mer Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	merestinib bioactivity Tyrosine-protein kinase receptor Tie-1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	merestinib positively regulates BMP4 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	merestinib bioactivity Angiopoietin-1 receptor Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	merestinib negatively regulates ITGAE Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	merestinib positively regulates SCGB2A1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	merestinib negatively regulates IGFBP5 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS

BRD-K18961567-001-01-1

Substance (Entity type)

A Substance

merestinib negatively regulates SNAP25

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

merestinib negatively regulates CHIC2

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

merestinib bioactivity Tyrosine-protein kinase Mer

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

merestinib bioactivity Tyrosine-protein kinase receptor Tie-1

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

merestinib positively regulates BMP4

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

merestinib bioactivity Angiopoietin-1 receptor

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

merestinib negatively regulates ITGAE

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

merestinib positively regulates SCGB2A1

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

merestinib negatively regulates IGFBP5

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.